CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $10.1M | 0.09% |
238,844
+50,692
| +27% | +$2.14M |
|
227
T Rowe Price
TROW
$23.8B
| $10.1M | 0.09% |
78,736
-8,344
| -10% | -$1.07M |
|
228
Exxon Mobil
XOM
$466B
| $10M | 0.09% |
291,691
-523,374
| -64% | -$18M |
|
229
Verisk Analytics
VRSK
$37.8B
| $9.99M | 0.09% |
53,928
+9,637
| +22% | +$1.79M |
|
230
Costco
COST
$427B
| $9.99M | 0.09% |
28,130
-2,398
| -8% | -$851K |
|
231
Workday
WDAY
$61.7B
| $9.96M | 0.09% |
46,293
+33,898
| +273% | +$7.29M |
|
232
Charles River Laboratories
CRL
$8.07B
| $9.93M | 0.09% |
+43,846
| New | +$9.93M |
|
|
ETFC
233
DELISTED
E*Trade Financial Corporation
ETFC
| $9.85M | 0.09% |
196,829
-1,443
| -0.7% | -$72.2K |
|
234
Colgate-Palmolive
CL
$68.8B
| $9.81M | 0.09% |
127,115
+5,819
| +5% | +$449K |
|
|
TWTR
235
DELISTED
Twitter, Inc.
TWTR
| $9.78M | 0.09% |
+174,127
| New | +$9.78M |
|
|
HES
236
DELISTED
Hess
HES
| $9.73M | 0.09% |
237,748
+212,590
| +845% | +$8.7M |
|
237
MetLife
MET
$52.9B
| $9.73M | 0.09% |
261,791
+7,297
| +3% | +$271K |
|
|
HOLI
238
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $9.73M | 0.09% |
880,226
-11,222
| -1% | -$124K |
|
|
IGMS
239
DELISTED
IGM Biosciences
IGMS
| $9.62M | 0.09% |
130,287
-6,081
| -4% | -$449K |
|
|
MOR
240
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $9.53M | 0.09% |
303,682
+36,932
| +14% | +$1.16M |
|
|
MXIM
241
DELISTED
Maxim Integrated Products
MXIM
| $9.48M | 0.09% |
140,220
+131,473
| +1,503% | +$8.89M |
|
242
Honeywell
HON
$136B
| $9.48M | 0.09% |
57,576
-48,111
| -46% | -$7.92M |
|
243
Insmed
INSM
$30.7B
| $9.38M | 0.09% |
292,000
| – | – |
|
|
EIDX
244
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $9.38M | 0.09% |
185,721
| – | – |
|
245
EPAM Systems
EPAM
$9.44B
| $9.15M | 0.09% |
28,300
-2,500
| -8% | -$808K |
|
246
Stryker
SYK
$150B
| $9.13M | 0.09% |
43,839
-1,021
| -2% | -$213K |
|
247
Pan American Silver
PAAS
$14.6B
| $9.13M | 0.09% |
284,000
-76,000
| -21% | -$2.44M |
|
|
SAGE
248
DELISTED
Sage Therapeutics
SAGE
| $9.13M | 0.09% |
+149,300
| New | +$9.13M |
|
|
ALLK
249
DELISTED
Allakos
ALLK
| $9.11M | 0.09% |
111,872
| – | – |
|
|
AIMT
250
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $9.05M | 0.09% |
+262,804
| New | +$9.05M |
|